93 related articles for article (PubMed ID: 15707952)
1. A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by beta-amyloid (1-42).
Lee KH; Shin BH; Shin KJ; Kim DJ; Yu J
Biochem Biophys Res Commun; 2005 Mar; 328(4):816-23. PubMed ID: 15707952
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
[TBL] [Abstract][Full Text] [Related]
3. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
4. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
5. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.
Kanapathipillai M; Lentzen G; Sierks M; Park CB
FEBS Lett; 2005 Aug; 579(21):4775-80. PubMed ID: 16098972
[TBL] [Abstract][Full Text] [Related]
6. Mulberry leaf extract prevents amyloid beta-peptide fibril formation and neurotoxicity.
Niidome T; Takahashi K; Goto Y; Goh S; Tanaka N; Kamei K; Ichida M; Hara S; Akaike A; Kihara T; Sugimoto H
Neuroreport; 2007 May; 18(8):813-6. PubMed ID: 17471072
[TBL] [Abstract][Full Text] [Related]
7. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
[TBL] [Abstract][Full Text] [Related]
8. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
9. A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro.
Nakagami Y; Nishimura S; Murasugi T; Kaneko I; Meguro M; Marumoto S; Kogen H; Koyama K; Oda T
Br J Pharmacol; 2002 Nov; 137(5):676-82. PubMed ID: 12381681
[TBL] [Abstract][Full Text] [Related]
10. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.
Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR
Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333
[TBL] [Abstract][Full Text] [Related]
11. A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes.
Maezawa I; Hong HS; Wu HC; Battina SK; Rana S; Iwamoto T; Radke GA; Pettersson E; Martin GM; Hua DH; Jin LW
J Neurochem; 2006 Jul; 98(1):57-67. PubMed ID: 16805796
[TBL] [Abstract][Full Text] [Related]
12. l-3-n-Butylphthalide ameliorates beta-amyloid-induced neuronal toxicity in cultured neuronal cells.
Peng Y; Xing C; Lemere CA; Chen G; Wang L; Feng Y; Wang X
Neurosci Lett; 2008 Mar; 434(2):224-9. PubMed ID: 18328624
[TBL] [Abstract][Full Text] [Related]
13. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
[TBL] [Abstract][Full Text] [Related]
14. Comparison of donepezil and memantine for protective effect against amyloid-beta(1-42) toxicity in rat septal neurons.
Kimura M; Komatsu H; Ogura H; Sawada K
Neurosci Lett; 2005 Dec; 391(1-2):17-21. PubMed ID: 16154269
[TBL] [Abstract][Full Text] [Related]
15. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
Yoshiike Y; Akagi T; Takashima A
Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K
Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054
[TBL] [Abstract][Full Text] [Related]
17. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
18. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of pyrroloquinoline quinone against Abeta-induced neurotoxicity in human neuroblastoma SH-SY5Y cells.
Zhang JJ; Zhang RF; Meng XK
Neurosci Lett; 2009 Oct; 464(3):165-9. PubMed ID: 19699263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
